Pharmacological Evaluation and Docking Studies of 3‐Thiadiazolyl‐and Thioxo‐1, 2, 4‐triazolylcoumarin Derivatives as Cholinesterase Inhibitors
Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) is considered a
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl-and Thioxo-1, 2, 4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors.
A Raza, A Saeed, A Ibrar, M Muddassar… - ISRN …, 2012 - search.ebscohost.com
Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) is considered a
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl-and Thioxo-1, 2, 4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors
A Raza, A Saeed, A Ibrar, M Muddassar… - ISRN …, 2012 - pubmed.ncbi.nlm.nih.gov
Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) is considered a
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
[PDF][PDF] Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl-and Thioxo-1, 2, 4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors
A Raza, A Saeed, A Ibrar, M Muddassar, AA Khan… - 2012 - researchgate.net
Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) is considered a
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
[PDF][PDF] Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl-and Thioxo-1, 2, 4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors
A Raza, A Saeed, A Ibrar, M Muddassar, AA Khan… - 2012 - cyberleninka.org
Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) is considered a
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
[HTML][HTML] Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl-and Thioxo-1, 2, 4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors
A Raza, A Saeed, A Ibrar, M Muddassar… - ISRN …, 2012 - ncbi.nlm.nih.gov
Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) is considered a
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl-and Thioxo-1, 2, 4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors
A Raza, A Saeed, A Ibrar, M Muddassar… - ISRN …, 2012 - search.proquest.com
Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) is considered a
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
[PDF][PDF] Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl-and Thioxo-1, 2, 4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors
A Raza, A Saeed, A Ibrar, M Muddassar, AA Khan… - 2012 - pdfs.semanticscholar.org
Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) is considered a
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl-and Thioxo-1, 2, 4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors.
A Raza, A Saeed, A Ibrar, M Muddassar… - ISRN …, 2012 - europepmc.org
Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) is considered a
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
[PDF][PDF] Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl-and Thioxo-1, 2, 4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors
A Raza, A Saeed, A Ibrar, M Muddassar, AA Khan… - 2012 - Citeseer
Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) is considered a
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …
promising strategy for the treatment of Alzheimer's disease (AD). This research project aims …